amifostine anhydrous has been researched along with Congenital Familial Lymphedema in 1 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
| Excerpt | Relevance | Reference |
|---|---|---|
| " These pre-clinical findings provide proof-of-principle to further delineate specific mechanisms underlying amifostine's beneficial effects, determine optimal amifostine-radiation therapy dosing regimens, and thereby expedite translation into clinical trials to reduce lymphedema incidence and severity in cancer patients at high lymphedema risk in whom radiation therapy is the recommended therapy." | 1.36 | Radioprotection from radiation-induced lymphedema without tumor protection. ( Bernas, MJ; Bracamonte, F; Daley, SK; Hirleman, ED; McKenna, M; Stea, BD; Stejskal, A; Witte, MH, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Daley, SK | 1 |
| Bernas, MJ | 1 |
| Stea, BD | 1 |
| Bracamonte, F | 1 |
| McKenna, M | 1 |
| Stejskal, A | 1 |
| Hirleman, ED | 1 |
| Witte, MH | 1 |
1 other study available for amifostine anhydrous and Congenital Familial Lymphedema
| Article | Year |
|---|---|
Radioprotection from radiation-induced lymphedema without tumor protection.
Topics: Amifostine; Animals; Colony-Forming Units Assay; Female; Humans; Incidence; Lymphatic Vessels; Lymph | 2010 |